Federal Register / Vol. 82, No. 156 / Tuesday, August 15, 2017 / Notices 38711 

Solutions Corp (S3), Bethesda, MD; 

Glover 38th Street Holdings LLC, 

Smithfield, VA; KAB Laboratories, Inc., 

San Diego, CA; Tektronix, Inc., 

Beaverton, OR; ORSA Technologies, 

LLC, Sierra Vista, AZ; DEEPSIG, Inc., 

Arlington, VA; QRC Technologies, 

Fredericksburg, VA; Freedom 

Technologies, Inc., Arlington, VA; Gigatronics, Incorporated, Dublin, CA; 

Cambium Networks, Inc., Rolling 

Meadows, IL; Epiq Solutions, 

Schaumburg, IL; LinQuest Corporation, 

Los Angeles, CA; Syncopated 

Engineering, Inc., Ellicott City, MD; 

Bascom Hunter Technologies, Inc., 

Baton Rouge, LA; InCadence Strategic 

Solutions, Manassas, VA; and Long 

Wave, Inc., Oklahoma City, OK, have 

been added as parties to this venture. 

Also, Hercules Research LLC, 

Chantilly, WA, has withdrawn from this 

venture. 

No other changes have been made in 

either the membership or planned 

activity of the group research project. 

Membership in this group research 

project remains open, and NSC intends 

to file additional written notifications 

disclosing all changes in membership. 

On May 24, 2014, NSC filed its 

original notification pursuant to section 

6(a) of the Act. The Department of 

Justice published a notice in the Federal 

Register pursuant to section 6(b) of the 

Act on November 4, 2014 (72 FR 65424). 

The last notification was filed with 

the Department on April 10, 2017. A 

notice was published in the Federal 

Register pursuant to section 6(b) of the 

Act on May 12, 2017 (82 FR 22160). 

Patricia A. Brink, 

Director of Civil Enforcement, Antitrust 

Division. 

[FR Doc. 2017–17148 Filed 8–14–17; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF JUSTICE 

Antitrust Division 

Notice Pursuant to the National 

Cooperative Research and Production 

Act of 1993—Network Centric 

Operations Industry Consortium, Inc. 

Notice is hereby given that, on July 

11, 2017, pursuant to section 6(a) of the 

National Cooperative Research and 

Production Act of 1993, 15 U.S.C. 4301 

et seq. (‘‘the Act’’), Network Centric 

Operations Industry Consortium, Inc. 

(‘‘NCOIC’’) has filed written 

notifications simultaneously with the 

Attorney General and the Federal Trade 

Commission disclosing changes in its 

membership. The notifications were 

filed for the purpose of extending the 

Act’s provisions limiting the recovery of 

antitrust plaintiffs to actual damages 

under specified circumstances. 

Specifically, Lewis Combs (individual 

member), Cincinnati, OH, has been 

added as a party to this venture. 

Also, Tata Power SED, Mumbai, 

INDIA; and beamSmart, Vienna, VA, 

have withdrawn as parties to this 

venture. 

No other changes have been made in 

either the membership or planned 

activity of the group research project. 

Membership in this group research 

project remains open, and NCOIC 

intends to file additional written 

notifications disclosing all changes in 

membership. 

On November 19, 2004, NCOIC filed 

its original notification pursuant to 

section 6(a) of the Act. The Department 

of Justice published a notice in the 

Federal Register pursuant to section 

6(b) of the Act on February 2, 2005 (70 

FR 5486). 

The last notification was filed with 

the Department on March 13, 2017. A 

notice was published in the Federal 

Register pursuant to section 6(b) of the 

Act on April 4, 2017 (82 FR 16420). 

Patricia A. Brink, 

Director of Civil Enforcement, Antitrust 

Division. 

[FR Doc. 2017–17150 Filed 8–14–17; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

Raman I. Popli, M.D.; Decision and 

Order 

On May 4, 2017, the Assistant 

Administrator, Diversion Control 

Division, Drug Enforcement 

Administration (hereinafter, DEA or 

Government), issued an Order to Show 

Cause to Raman Popli, M.D. 

(hereinafter, Registrant) of McHenry, 

Illinois, the holder of Certificate of 

Registration No. BP7189067. GX 2 

(Registration Certificate). The Show 

Cause Order proposed the revocation of 

Registrant’s Certificate of Registration 

on the ground that Registrant does ‘‘not 

have authority to handle controlled 

substances in the State of Illinois,’’ the 

State in which he is registered. GX 1, at 

1 (citing 21 U.S.C. 823(f) and 824(a)(3)). 

As the jurisdictional basis for the 

proceeding, the Show Cause Order 

alleged that registration BP7189067, 

pursuant to which Registrant is 

authorized to prescribe controlled 

substances in Schedules II through V, 

expires on March 31, 2019. Id. 

As the substantive grounds for the 

proceeding, the Show Cause Order 

alleged that Registrant currently lacks 

‘‘authority to handle controlled 

substances in the State of Illinois.’’ Id. 

It alleged that, on March 13, 2017, 

Illinois suspended Registrant’s 

‘‘authority to prescribe and administer 

controlled substances.’’ Id. 

The Show Cause Order notified 

Registrant of his right to request a 

hearing on the allegation or to submit a 

written statement while waiving his 

right to a hearing, the procedures for 

electing each option, and the 

consequences for failing to elect either 

option. Id. at 2, citing 21 CFR 1301.43. 

The Show Cause Order also notified 

Registrant of the opportunity to submit 

a corrective action plan. Id., citing 21 

U.S.C. 824(c)(2)(C). 

On May 5, 2017, a DEA Office of Chief 

Counsel Legal Assistant faxed and 

mailed ‘‘via USPS First Class Mail’’ a 

copy of the Show Cause Order to 

Registrant’s attorney, Alan Rhine, Esq., 

at the fax number and business address 

he provided. GX 5, at 1 (Legal Assistant 

Declaration dated June 8, 2017) and 

attachment. The Legal Assistant’s 

Declaration appended emails to and 

from Registrant’s attorney confirming 

that Registrant authorized him to accept 

service of documents from the DEA on 

Registrant’s behalf. Id. I find that the 

Government’s service of the Show Cause 

Order on Registrant was legally 

sufficient. 

The Government submitted a Request 

for Final Agency Action (hereinafter, 

RFAA) dated June 9, 2017 and an 

evidentiary record to support the Show 

Cause Order’s allegations. According to 

the Government’s representations in the 

RFAA, ‘‘more than thirty days have 

passed since the Order to Show Cause 

was served on Respondent and no 

request for hearing has been received by 

DEA, and . . . no written statement or 

other correspondence has been filed in 

lieu of a hearing request.’’ RFAA, at 1. 

Based on the Government’s 

representations and my review of the 

record, I find that more than 30 days 

have now passed since the date of 

service of the Show Cause Order on 

Registrant through his attorney, and that 

neither Registrant, his attorney, nor 

anyone else purporting to represent 

him, has requested a hearing or 

submitted a written statement while 

waiving his right to a hearing. 

Accordingly, I find that Registrant has 

waived his right to a hearing and his 

right to submit a written statement. 21 

CFR 1301.43(d). I therefore issue this 

Decision and Order based on the record 

submitted by the Government. 21 CFR 

1301.43(e). 

mstockstill on DSK30JT082PROD with NOTICES

38712 Federal Register / Vol. 82, No. 156 / Tuesday, August 15, 2017 / Notices 

1Since the pages in GX 3 are not consecutively 

paginated, this Decision and Order identifies the 

relevant document in GX 3 and the relevant page 

number of that document. 

2For the same reasons the Division of 

Professional Regulation of the Illinois Department 

of Financial and Professional Regulation suspended 

Registrant’s Illinois Physician and Surgeon License 

and Illinois Controlled Substance License, I find 

that the public interest necessitates that this Order 

be effective immediately. 21 CFR 1316.67. 

Findings of Fact 

Registrant’s DEA Registration 

Registrant currently holds DEA 

practitioner registration BP7189067 

authorizing him to dispense controlled 

substances in Schedules II through V. 

GX 2. This registration expires on March 

31, 2019. Id. 

DEA practitioner registration 

BP7189067 is assigned to Registrant at 

‘‘Dr Raman Popli and Associates, Ltd, 

5415 Bull Valley Road, McHenry, IL 

60050.’’ Id. 

The Status of Registrant’s State Licenses 

On March 13, 2017, the Director of the 

Division of Professional Regulation of 

the Illinois Department of Financial and 

Professional Regulation issued an Order 

suspending Registrant’s Illinois 

Physician and Surgeon License No. 

036–104035 and Illinois Controlled 

Substance License No. 336–064820 

pending proceedings before an 

Administrative Law Judge at the 

Department of Financial and 

Professional Regulation and the Medical 

Disciplinary Board of the State of 

Illinois. GX 3 (Order, at 1–2).1

According to the Order, ‘‘the public 

interest, safety and welfare imperatively 

require emergency action to prevent the 

continued practice of Raman Popli, 

M.D., Respondent, in that Respondent’s 

actions constitute an immediate danger 

to the public.’’ Id. (Order, at 1). 

Discussion 

Pursuant to 21 U.S.C. 824(a)(3), the 

Attorney General is authorized to 

suspend or revoke a registration issued 

under section 823 of the Controlled 

Substances Act (hereinafter, CSA), 

‘‘upon a finding that the registrant . . . 

has had his State License . . . 

suspended [or] . . . revoked by 

competent State authority and is no 

longer authorized by State law to engage 

in the . . . dispensing of controlled 

substances.’’ With respect to a 

practitioner, the DEA has also long held 

that the possession of authority to 

dispense controlled substances under 

the laws of the State in which a 

practitioner engages in professional 

practice is a fundamental condition for 

obtaining and maintaining a 

practitioner’s registration. See, e.g., 

James L. Hooper, 76 FR 71,371 (2011), 

pet. for rev. denied, 481 Fed. Appx. 826 

(4th Cir. 2012); Frederick Marsh 

Blanton, 43 FR 27,616 (1978). 

This rule derives from the text of two 

provisions of the CSA. First, Congress 

defined the term ‘‘ ‘practitioner’ [to] 

mean[ ] a . . . physician, dentist, . . . 

or other person licensed, registered, or 

otherwise permitted, by . . . the 

jurisdiction in which he practices . . ., 

to distribute, dispense, [or] administer 

. . . a controlled substance in the 

course of professional practice . . . .’’ 

21 U.S.C. 801(21). Second, in setting the 

requirements for obtaining a 

practitioner’s registration, Congress 

directed that ‘‘[t]he Attorney General 

shall register practitioners . . . if the 

applicant is authorized to dispense . . . 

controlled substances under the laws of 

the State in which he practices.’’ 21 

U.S.C. 823(f). Because Congress has 

clearly mandated that a practitioner 

possess state authority in order to be 

deemed a practitioner under the CSA, 

the DEA has held repeatedly that 

revocation of a practitioner’s registration 

is the appropriate sanction whenever he 

is no longer authorized to dispense 

controlled substances under the laws of 

the State in which he practices. See, 

e.g., Hooper, 76 FR at 71,371–72; Sheran 

Arden Yeates, 71 FR 39,130, 39,131 

(2006); Dominick A. Ricci, 58 FR 51,104, 

51,105 (1993); Bobby Watts, 53 FR 

11,919, 11,920 (1988); Blanton, 43 FR at 

27,616. 

Under Illinois law, ‘‘[n]o person shall 

practice medicine . . . without a valid, 

active license to do so . . . .’’ 225 ILCS 

60/3 (2017). Further, ‘‘[e]very person 

who . . . dispenses any controlled 

substances . . . must obtain a 

registration issued by the [Illinois] 

Department of Financial and 

Professional Regulation in accordance 

with its rules.’’ 720 ILCS 570/302(a). 

In this case, the Division of 

Professional Regulation of the Illinois 

Department of Financial and 

Professional Regulation took emergency 

action to suspend Registrant’s Physician 

and Surgeon License and Illinois 

Controlled Substance License. Supra. 

Consequently, Registrant is not 

currently authorized to handle 

controlled substances in the State of 

Illinois, the State in which he is 

registered, and he is not entitled to 

maintain his registration. Blanton, 

supra. Accordingly, I will order this his 

registration be revoked and that any 

pending application for the renewal or 

modification of his registration be 

denied. 21 U.S.C. 824(a)(3) and 823(f). 

Order 

Pursuant to the authority vested in me 

by 21 U.S.C. 824(a), as well as 28 CFR 

0.100(b), I order that DEA Certificate of 

Registration BP7189067 issued to 

Raman I. Popli, M.D., as well as DATAWaiver Identification No. XP7189067, 

be, and they hereby are, revoked. I 

further order that any pending 

application of Raman I. Popli, M.D., to 

renew or modify this registration, as 

well as any other pending application 

by him for registration in the State of 

Illinois, be, and it hereby is, denied. 

This order is effective immediately.2

Dated: August 4, 2017. 

Chuck Rosenberg, 

Acting Administrator. 

[FR Doc. 2017–17146 Filed 8–14–17; 8:45 am] 

BILLING CODE 4410–09–P 

LEGAL SERVICES CORPORATION 

Sunshine Act Meeting Notice 

DATE AND TIME: The Legal Services 

Corporation’s Finance Committee will 

meet telephonically on August 21, 2017. 

The meeting will commence at 12:00 

p.m., EDT, and will continue until the 

conclusion of the Committee’s agenda. 

LOCATION: John N. Erlenborn Conference 

Room, Legal Services Corporation 

Headquarters, 3333 K Street NW., 

Washington, DC 20007. 

PUBLIC OBSERVATION: Members of the 

public who are unable to attend in 

person but wish to listen to the public 

proceedings may do so by following the 

telephone call-in directions provided 

below. 

CALL-IN DIRECTIONS FOR OPEN SESSIONS: 

• Call toll-free number: 1–866–451– 

4981; 

• When prompted, enter the 

following numeric pass code: 

5907707348; 

• When connected to the call, please 

immediately ‘‘MUTE’’ your telephone. 

Members of the public are asked to 

keep their telephones muted to 

eliminate background noises. To avoid 

disrupting the meeting, please refrain 

from placing the call on hold if doing so 

will trigger recorded music or other 

sound. From time to time, the Chair may 

solicit comments from the public. 

STATUS OF MEETING: Open. 

MATTERS TO BE CONSIDERED: 

1. Approval of agenda 

2. Approval of minutes of the 

Committee’s Open Session 

telephonic meeting of June 21, 2017 

3. Approval of minutes of the 

Committee’s Open Session 

telephonic meeting of June 26, 2017 

mstockstill on DSK30JT082PROD with NOTICES